Common use of USE OF NAMES AND PUBLICATION Clause in Contracts

USE OF NAMES AND PUBLICATION. 13.1 Nothing contained in this Agreement shall be construed as granting any right to the Company or its Affiliates to use in advertising, publicity, or other promotional activities any name, trade name, trademark, or other designation of the Licensor or any of its units (including contraction, abbreviation or simulation of any of the foregoing) without the prior, written consent of the Licensor; provided, however, that the Licensor acknowledges and agrees that the Company may use the name of the Licensor in various documents used by the Company for capital raising and financing without such prior written consent where the use of such names may be required by law. The Company agrees to promptly provide the Licensor with a copy of any documents used by the Company, which contain the name of the Licensor. The Licensor may act as a consultant and scientific advisor to the Company with respect to the licenses granted to the Company hereunder, subject to the policies, if any, of the Licensor. 13.2 Nothing herein shall be deemed to establish a relationship of principal and agent between the Licensor and the Company, nor any of their agents or employees for any purpose whatsoever. This Agreement shall not be construed as creating a partnership between the Licensor and the Company, or as creating any other form of legal association or arrangement which would impose liability upon one party for the act or failure to act of the other party. 13.3 In the event that the Licensor desires to publish or disclose, by written, oral or other presentation, Know-how, Patent Rights, or any material information related thereto then the Licensor shall notify the Company in writing by facsimile where confirmed by the receiving party, and/or by certified or registered mail (return receipt requested) of its intention at least sixty (60) days prior to any speech, lecture or other oral presentation and at least sixty (60) days before any written or other publication or disclosure. The Licensor shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. The Company may request that the Licensor, no later than thirty (30) days following the receipt of such notice, delay such presentation, publication or disclosure in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related to the information to be disclosed or request that the Licensor does so. Upon receipt of such request to delay such presentation, publication or disclosure, the Licensor shall arrange for a delay of such presentation, publication or disclosure until the earlier to occur of (a) to ninety (90) days and (b) such time as the Company or the Licensor has filed, or has had filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and the Licensor. If the Licensor does not receive any such request from the Company to delay such presentation, publication or disclosure, the Licensor may submit such material for presentation, publication or other form of disclosure.

USE OF NAMES AND PUBLICATION. 13.1 Nothing contained in this Agreement shall be construed as granting any right to the Company or its Affiliates to use in advertising, publicity, or other promotional activities any name, trade name, trademark, or other designation of the Licensor or any of its units (including contraction, abbreviation or simulation of any of the foregoing) without the prior, written consent of the Licensor; provided, however, that the Licensor acknowledges and agrees that the Company may use the name of the Licensor in various documents used by the Company for capital raising and financing without such prior written consent where the use of such names may be required by law. The Company agrees to promptly provide the Licensor with a copy of any documents used by the Company, which contain the name of the Licensor. The Licensor may act as a consultant and scientific advisor to the Company with respect to the licenses granted to the Company hereunder, subject to the policies, if any, of the Licensor. 13.2 Nothing herein shall be deemed to establish a relationship of principal and agent between the Licensor and the Company, nor any of their agents or employees for any purpose whatsoever. This Agreement shall not be construed as creating a partnership between the Licensor and the Company, or as creating any other form of legal association or arrangement arrangement, which would impose liability upon one party for the act or failure to act of the other party. 13.3 In Notwithstanding the provisions of Article 15 hereof, in the event that the Licensor desires to publish or disclose, by written, oral or other presentation, Know-how, Patent Rights, or any material information related thereto then the Licensor shall notify the Company in writing by facsimile where confirmed by the receiving party, and/or by certified or registered mail (return receipt requested) of its intention at least sixty (60) days prior to any speech, lecture or other oral presentation and at least sixty (60) days before any written or other publication or disclosure. The Licensor shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. The Company may request that the Licensor, no later than thirty sixty (3060) days following the receipt of such notice, delay such presentation, publication or disclosure in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related to the information to be disclosed or request that the Licensor does so. Upon receipt of such request to delay such presentation, publication or disclosure, the Licensor shall arrange for a delay of such presentation, publication or disclosure until the earlier to occur of (a) to ninety (90) days and (b) such time as the Company or the Licensor has filed, or has had filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and the Licensor. This delay will not exceed thirty (30) days. If the Licensor does not timely receive any such request from the Company to delay such presentation, publication or disclosure, the Licensor may submit such material for presentation, publication or other form of disclosure.

USE OF NAMES AND PUBLICATION. 13.1 Nothing contained in this Agreement shall be construed as granting any right to the Company or its Affiliates to use in advertising, publicity, or other promotional activities any name, trade name, trademark, or other designation of the Licensor or any of its units (including contraction, abbreviation or simulation of any of the foregoing) without the prior, written consent of the Licensor; provided, however, that the Licensor acknowledges and agrees that the Company may use the name of the Licensor in various documents used by the Company for capital raising and financing without such prior written consent where the use of such names may be required by law. The Company agrees to promptly provide the Licensor with a copy of any documents used by the Company, which contain the name of the Licensor. The Licensor may act as a consultant and scientific advisor to the Company with respect to the licenses granted to the Company hereunder, subject to the policies, if any, of the Licensor. 13.2 Nothing herein shall be deemed to establish a relationship of principal and agent between the Licensor and the Company, nor any of their agents or employees for any purpose whatsoever. This Agreement shall not be construed as creating a partnership between the Licensor and the Company, or as creating any other form of legal association or arrangement which would impose liability upon one party for the act or failure to act of the other party. 13.3 In the event that the Licensor desires to publish or disclose, by written, oral or other presentation, Know-how, Patent Rights, or any material information related thereto then the Licensor shall use its best efforts to notify the Company in writing by facsimile where confirmed by the receiving party, and/or by certified or registered mail (return receipt requested) of its intention at least sixty (60) 60 days prior to any speech, lecture or other oral presentation and at least sixty (60) 60 days before any written or other publication or disclosure. The Licensor shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. The Company may request that the Licensor, no later than thirty (30) 30 days following the receipt of such notice, delay such presentation, publication or disclosure in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related to the information to be disclosed or request that the Licensor does so. Upon receipt of such request to delay such presentation, publication or disclosure, the Licensor shall arrange for a delay of such presentation, publication or disclosure until the earlier to occur of (a) to ninety (90) 90 days and (b) such time as the Company or the Licensor has filed, or has had filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and the Licensor. If the Licensor does not receive any such request from the Company to delay such presentation, publication or disclosure, the Licensor may submit such material for presentation, publication or other form of disclosure.

USE OF NAMES AND PUBLICATION. 13.1 Nothing contained in this Agreement shall be construed as granting any right to the Company or its Affiliates to use in advertising, publicity, or other promotional activities any name, trade name, trademark, or other designation of the Licensor or any of its units (including contraction, abbreviation or simulation of any of the foregoing) without the prior, written consent of the Licensor; provided, however, that the Licensor acknowledges and agrees that the Company may use the name names of the Licensor in various documents used by the Company for capital raising and financing without such prior written consent where the use of such names may be required by law. The Company agrees to promptly provide the Licensor with a copy of any documents used by the Company, which contain the name of the Licensor. The Licensor may act as a consultant and scientific advisor to the Company with respect to the licenses granted to the Company hereunder, subject to the policies, if any, of the Licensor. 13.2 Nothing herein shall be deemed to establish a relationship of principal and agent between the Licensor and the Company, nor any of their agents or employees for any purpose whatsoever. This Agreement shall not be construed as creating a partnership between the Licensor and the Company, or as creating any other form of legal association or arrangement which would impose liability upon one party for the act or failure to act of the other party. 13.3 In the event that the Licensor desires to publish or disclose, by written, oral or other presentation, Patent Rights, Know-how, Patent Rights, or any material information related thereto then the Licensor shall notify the Company and in writing by facsimile where confirmed by the receiving party, and/or by certified or registered mail (return receipt requested) of its their intention at least sixty (60) [*] days prior to any speech, lecture or other oral presentation and at least sixty (60) [*] days before any written or other publication or disclosure. The Licensor shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. The Company may request that the Licensor, no later than thirty (30) [*] days following the receipt of such notice, delay such presentation, publication or disclosure for up to an additional [*] days in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related to the information to be disclosed or request that the Licensor does do so. Upon receipt of such request to delay such presentation, publication or disclosure, the Licensor shall arrange for a delay of such presentation, publication or disclosure until the earlier to occur of (a) to ninety (90) days and (b) such time as the Company or the Licensor has have filed, or has had filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and the Licensor. If the Licensor does not receive any such request from the Company to delay such presentation, publication or disclosure, the Licensor may submit such material for presentation, publication or other form of disclosure.

USE OF NAMES AND PUBLICATION. 13.1 Nothing contained in this Agreement shall be construed as granting any right to the Company or its Affiliates to use in advertising, publicity, or other promotional activities any name, trade name, trademark, or other designation of Licensor, the Licensor or inventors, the University nor any of its employees, any of its units (including contraction, abbreviation or simulation of any of the foregoing) ), nor any adaptation thereof, without the prior, written consent of the Licensor; provided, however, that the Licensor acknowledges and agrees that the Company may use the name state that such has been licensed by Licensor under one or more of the Licensor in various documents used by patents and/or applications comprising the Company for capital raising and financing without such prior written consent where the use of such names may be required by law. The Company agrees to promptly provide the Licensor with a copy of any documents used by the Company, which contain the name of the Licensor. The Licensor may act as a consultant and scientific advisor to the Company with respect to the licenses granted to the Company hereunder, subject to the policies, if any, of the LicensorPatent Rights. 13.2 Nothing herein shall be deemed to establish a relationship of principal and agent between the Licensor and the Company, nor any of their agents or employees for any purpose whatsoever. This Agreement shall not be construed as creating a partnership between the Licensor and the Company, or as creating any other form of legal association or arrangement which would impose liability upon one party for the act or failure to act of the other party. 13.3 In the event that the Licensor desires to publish or disclose, by written, oral or other presentation, Patent Rights, Know-how, Patent Rights, or any material information related thereto then the Licensor shall notify the Company and in writing by facsimile where confirmed by the receiving party, and/or by certified or registered mail (return receipt requested) of its their intention at least sixty (60) days prior to any speech, lecture or other oral presentation and at least sixty ninety (6090) days before any written or other publication or disclosure. The Licensor shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. The Company may request that the Licensor, no later than thirty (30) days following the receipt of such notice, delay such presentation, publication or disclosure for up to an additional sixty (60) days in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related to the information to be disclosed or request that the Licensor does do so. Upon receipt of such request to delay such presentation, publication or disclosure, the Licensor shall arrange for a delay of such presentation, publication or disclosure until the earlier to occur of (a) to ninety (90) days and (b) such time as the Company or the Licensor has have filed, or has had filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and the Licensor. If the Licensor does not receive any such request from the Company to delay such presentation, publication or disclosure, the Licensor may submit such material for presentation, publication or other form of disclosure.

USE OF NAMES AND PUBLICATION. 13.1 14.1 Nothing contained in this Agreement shall be construed as granting any right to the Company or its Affiliates to use in advertising, publicity, or other promotional activities any name, trade name, trademark, or other designation of the Licensor or any of its units (including contraction, abbreviation or simulation of any of the foregoing) without the prior, written consent of the Licensor; provided, however, that the Licensor acknowledges and agrees that the Company may use the name of the Licensor and the names of the Principal Investigators in various documents used by the Company for capital raising and financing without such prior written consent where but only to the extent that such use of such names may be reasonably required by law. The Company agrees to promptly provide Licensor acknowledges that the Licensor with a copy of any documents used by the Company, which contain the name of the Licensor. The Licensor Principal Investigators may act as a consultant consultants and scientific advisor advisors to the Company with respect to the licenses granted to the Company hereunder, subject to the policies, if any, respective policies of the Licensor. 13.2 14.2 Nothing herein shall be deemed to establish a relationship of principal and agent between the Licensor and the Company, nor any of their agents or employees for any purpose whatsoever. This Agreement shall not be construed as creating a partnership between the Licensor and the Company, or as creating any other form of legal association or arrangement which would impose liability upon one party for the act or failure to act of the other party. 13.3 In 14.3 Except as set forth in paragraph 14.4, in the event that the Licensor desires or Principal Investigators desire, individually or as a group, to publish or disclose, by written, oral or other presentation, Know-how, Patent Rights, or any material information related thereto then the Licensor or the Principal Investigator(s) shall notify the Company in writing by facsimile where confirmed by the receiving party, and/or by certified or registered mail (return receipt requested) of its their intention at least sixty (60) days prior to any speech, lecture or other oral presentation and at least sixty (60) days before any written or other publication or disclosure. The Licensor Principal Investigator(s) shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. The Company may request that the Licensor, no No later than thirty (30) days following the receipt of such notice, the Company may request that the Principal Investigator(s) and the Licensor, delay such presentation, publication or disclosure for a reasonable period of time in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related to the information to be disclosed or request that the Licensor does do so. Upon receipt of such request to delay such presentation, publication or disclosure, the Licensor and the Principal Investigator(s) shall arrange for a delay of such presentation, publication or disclosure until the earlier to occur for a reasonable period of (a) to ninety (90) days and (b) such time as necessary for the Company or the Licensor has filedto file, or has had have filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and the Licensor; provided, however, that in no event shall such delay be greater than forty-five (45) days. If neither the Principal Investigator(s) nor the Licensor does not receive any such request from the Company to delay such presentation, publication or disclosure, the Licensor or the Principal Investigator(s) may submit such material for presentation, publication or other form of disclosure. 14.4 In the event that the N.I.H., or the Principal Investigator(s) of the N.I.H. (the "N.I.H. Investigator(s)"), desires, individually or as a group, to publish or disclose, by written, oral or other presentation, Know-how, Patent Rights, or any material information related thereto then the N.I.H. or the N.I.H. Investigator(s) shall notify the Company in writing by facsimile where confirmed by the receiving party, and/or by certified or registered mail (return receipt requested) of their intention at least thirty (30) days prior to any speech, lecture or other oral presentation and at least thirty (30) days before any written or other publication or disclosure. The N.I.H. Investigator(s) shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. No later than thirty (30) days following the receipt of such notice, the Company may request that the N.I.H. and the N.I.H. Investigator(s), delay such presentation, publication or disclosure for an additional period of thirty (30) days (which 30-day period shall not be renewable) in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related to the information to be disclosed or request that the N.I.H. do so. Upon receipt of such request to delay such presentation, publication or disclosure, the N.I.H. and the N.I.H. Investigator(s) shall arrange for a second thirty (30) day period of delay of such presentation, publication or disclosure so that the Company or the N.I.H. may file, or have filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and the N.I.H. If neither the N.I.H. nor the N.I.H. Investigator(s) receive any such request from the Company to delay such presentation, publication or disclosure, the N.I.H. or the N.I.H. Investigator(s) may submit such material for presentation, publication or other form of disclosure.

USE OF NAMES AND PUBLICATION. 13.1 Nothing contained in this Agreement shall be construed as granting any right to the Company or its Affiliates to use in advertising, publicity, or other promotional activities any name, trade name, trademark, or other designation of the Licensor or any of its units (including contraction, abbreviation or simulation of any of the foregoing) without the prior, written consent of the Licensor; provided, however, that the Licensor acknowledges and agrees that the Company may use the name names of the Licensor in various documents used by the Company for capital raising and financing without such prior written consent where the use of such names may be required by law. The Company agrees to promptly provide the Licensor with a copy of any documents used by the Company, which contain the name of the Licensor. The Licensor may act as a consultant and scientific advisor to the Company with respect to the licenses granted to the Company hereunder, subject to the policies, if any, of the Licensor. 13.2 Nothing herein shall be deemed to establish a relationship of principal and agent between the Licensor and the Company, nor any of their agents or employees for any purpose whatsoever. This Agreement shall not be construed as creating a partnership between the Licensor and the Company, or as creating any other form of legal association or arrangement which would impose liability upon one party for the act or failure to act of the other party. 13.3 In the event that the Licensor desires to publish or disclose, by written, oral or other presentation, Patent Rights, Know-how, Patent Rights, or any material information related thereto then the Licensor shall notify the Company in writing by facsimile where confirmed by the receiving party, and/or by certified or registered mail (return receipt requested) of its their intention at least sixty sixty- (60) days prior to any speech, lecture or other oral presentation and at least sixty ninety- (6090) days before any written or other publication or disclosure. The Licensor shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. The Company may request that the Licensor, no later than thirty thirty- (30) days following the receipt of such notice, delay such presentation, publication or disclosure for up to an additional sixty- (60) days in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related to the information to be disclosed or request that the Licensor does do so. Upon receipt of such request to delay such presentation, publication or disclosure, the Licensor shall arrange for a delay of such presentation, publication or disclosure until the earlier to occur of (a) to ninety (90) days and (b) such time as the Company or the Licensor has have filed, or has had filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and the Licensor. If the Licensor does not receive any such request from the Company to delay such presentation, publication or disclosure, the Licensor may submit such material for presentation, publication or other form of disclosure.

USE OF NAMES AND PUBLICATION. 13.1 14.1 Nothing contained in this Agreement shall be construed as granting any right to the Company or its Affiliates to use in advertising, publicity, or other promotional activities any name, trade name, trademark, or other designation of the Licensor or any of its units (including contraction, abbreviation or simulation of any of the foregoing) without the prior, written consent of the Licensor; provided, however, that the Licensor acknowledges and agrees that the Company may use the name names of the Licensor in various documents used by the Company for capital raising and financing without such prior written consent where the use of such names may be required by law. The Company agrees to promptly provide Notwithstanding the foregoing, the Licensor with a copy of any documents used by the Company, which contain the name of the Licensor. The Licensor may act as a consultant and scientific advisor hereby grants to the Company with respect for the term of this Agreement a non-exclusive, royalty free license to use any United States and/or foreign trademarks or trademark applications filed by or on behalf of the Licensor related to the licenses granted to Technology, the Company hereunderPatent Rights, subject to the policiesLicensed Products or Licensed Processes, if any, of the Licensorincluding NEUPREX(R). 13.2 14.2 Nothing herein shall be deemed to establish a relationship of principal and agent between the Licensor and the Company, nor any of their agents or employees for any purpose whatsoever. 14.3 The Licensor and the Company agree to the release of a press release in the form attached hereto as Schedule 14.3 upon full execution of this Agreement and that the consummation of this Agreement, as well as such terms as are expressly described in such press release, shall be deemed to be in the public domain. This Agreement shall not be construed as creating a partnership between Subject to either party's disclosure obligations under law, the Licensor and the Company, or as creating any Company shall cooperate with each other form in the development and distribution of legal association or arrangement which would impose liability upon one party all further news releases and other written statements for the act or failure to act of the other party. 13.3 In the event that the Licensor desires to publish or disclose, by written, oral or other presentation, Know-how, Patent Rights, or any material information related thereto then the Licensor shall notify the Company in writing by facsimile where confirmed by the receiving party, and/or by certified or registered mail (return receipt requested) of its intention at least sixty (60) days prior to any speech, lecture or other oral presentation and at least sixty (60) days before any written or other publication or disclosure. The Licensor shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. The Company may request that the Licensor, no later than thirty (30) days following the receipt of such notice, delay such presentation, publication or disclosure in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related general circulation relating primarily to the information to be disclosed or request that the Licensor does so. Upon receipt of such request to delay such presentation, publication or disclosure, the Licensor shall arrange for a delay of such presentation, publication or disclosure until the earlier to occur of (a) to ninety (90) days and (b) such time as the Company or the Licensor has filed, or has had filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and the Licensor. If the Licensor does not receive any such request from the Company to delay such presentation, publication or disclosure, the Licensor may submit such material for presentation, publication or other form of disclosuretransaction contemplated hereby.

USE OF NAMES AND PUBLICATION. 13.1 Nothing contained in this Agreement shall be construed as granting any right to the Company or its Affiliates or sublicensees to use in advertising, marketing, publicity, or other promotional activities any name, trade name, trademark, or other designation of the Licensor IGI or any of its units (including contraction, abbreviation or simulation of any of the foregoing) without the prior, prior written consent of the LicensorIGI; provided, however, that the Licensor IGI acknowledges and agrees that the Company may use the name names of the Licensor IGI in various documents used by the Company for capital raising and financing without such prior written consent where the use of such names may be required by law. The Company agrees to promptly provide the Licensor with a copy of any documents used by the Company, which contain the name of the Licensor. The Licensor may act as a consultant and scientific advisor to the Company with respect to the licenses granted to the Company hereunder, subject to the policies, if any, of the Licensor. 13.2 Nothing herein shall be deemed to establish a relationship of principal and agent between the Licensor IGI and the Company, nor any of their agents or employees for any purpose whatsoever. This Agreement shall not be construed as creating a partnership between the Licensor IGI and the Company, or as creating any other form of legal association or arrangement which would impose liability upon one party Party for the act or failure to act of the other partyParty. 13.3 In the event that the Licensor IGI desires to publish or disclose, by written, oral or other presentation, Know-howHow, PTH Patent Rights, or any material information related thereto then the Licensor IGI shall notify the Company in writing by facsimile where confirmed by the receiving partyParty, and/or by certified or registered mail (return receipt requested) of its their intention at least sixty thirty (6030) days prior to any speech, lecture or other oral presentation and at least sixty thirty (6030) days before any written or other publication or disclosure. The Licensor IGI shall include with such notice a description of any proposed oral presentation or, in any proposed written or other disclosure, a current draft of such proposed disclosure or abstract. The Company may request that the LicensorIGI, no later than thirty ten (3010) days following the receipt of such notice, to delay such presentation, publication or disclosure in order to enable the Company to file, or have filed on their behalf, a patent application, copyright or other appropriate form of intellectual property protection related to the information to be disclosed or request that the Licensor does sodisclosed. Upon receipt of such request to delay such presentation, publication or disclosure, the Licensor IGI shall arrange for a delay of such presentation, publication or disclosure until the earlier to occur of (a) to ninety (90) days and (b) such time as the Company or the Licensor has filed, or has had filed on its behalf, such patent application, copyright or other appropriate form of intellectual property protection in form and in substance reasonably satisfactory to the Company and Company, but in no case shall the Licensordelay be for a period of more than thirty (30) days. If the Licensor IGI does not receive any such request from the Company to delay such presentation, publication or disclosure, the Licensor IGI may submit such material for presentation, publication or other form of disclosure. 13.4 At any time after the Effective Date of this Agreement, either Party shall, at its sole cost and expense, be permitted to publicly announce, advertise, feature and/or otherwise market the business relationship between the Parties created under this Agreement in and through such print and other media vehicles as selected by the Parties. Each Party shall provide the other for its prior review and approval, at least seven (7) days prior to the proposed release date, with the form and substance of any and all such proposed announcements, advertising and/or features under this Article 13.4, which approval shall not be unreasonably withheld by such Party.